97 related articles for article (PubMed ID: 19583443)
1. Ligand-based dual target drug design for H1N1: swine flu--a preliminary first study.
Chen CY; Chang YH; Bau DT; Huang HJ; Tsai FJ; Tsai CH; Chen CY
J Biomol Struct Dyn; 2009 Oct; 27(2):171-8. PubMed ID: 19583443
[TBL] [Abstract][Full Text] [Related]
2. Potent inhibitor design against H1N1 swine influenza: structure-based and molecular dynamics analysis for M2 inhibitors from traditional Chinese medicine database.
Lin CH; Chang TT; Sun MF; Chen HY; Tsai FJ; Chang KL; Fisher M; Chen CY
J Biomol Struct Dyn; 2011 Feb; 28(4):471-82. PubMed ID: 21142218
[TBL] [Abstract][Full Text] [Related]
3. Binding mode analysis of anti-influenza drugs in H1N1 (2009) and H5N1 influenza A virus and designing of potential H1N1 inhibitors.
Singh KhD; Kirubakaran P; Nagamani S; Karthikeyan M
Int J Comput Biol Drug Des; 2015; 8(1):1-18. PubMed ID: 25869316
[TBL] [Abstract][Full Text] [Related]
4. High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan.
Chang SS; Huang HJ; Chen CY
Mol Biosyst; 2011 Dec; 7(12):3366-74. PubMed ID: 22012120
[TBL] [Abstract][Full Text] [Related]
5. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
[TBL] [Abstract][Full Text] [Related]
6. Screening from the world's largest TCM database against H1N1 virus.
Chang TT; Sun MF; Chen HY; Tsai FJ; Fisher M; Lin JG; Chen CY
J Biomol Struct Dyn; 2011 Apr; 28(5):773-86. PubMed ID: 21294588
[TBL] [Abstract][Full Text] [Related]
7. 3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase.
Gao L; Zu M; Wu S; Liu AL; Du GH
Bioorg Med Chem Lett; 2011 Oct; 21(19):5964-70. PubMed ID: 21843936
[TBL] [Abstract][Full Text] [Related]
8. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
[TBL] [Abstract][Full Text] [Related]
9. Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus.
Woods CJ; Malaisree M; Pattarapongdilok N; Sompornpisut P; Hannongbua S; Mulholland AJ
Biochemistry; 2012 May; 51(21):4364-75. PubMed ID: 22574858
[TBL] [Abstract][Full Text] [Related]
10. Influenza a (H1N1) outbreak and challenges for pharmacotherapy.
Chawla R; Sharma RK; Bhardwaj JR
Indian J Physiol Pharmacol; 2009; 53(2):113-26. PubMed ID: 20112815
[TBL] [Abstract][Full Text] [Related]
11. Evolution of human receptor binding affinity of H1N1 hemagglutinins from 1918 to 2009 pandemic influenza A virus.
Nunthaboot N; Rungrotmongkol T; Malaisree M; Kaiyawet N; Decha P; Sompornpisut P; Poovorawan Y; Hannongbua S
J Chem Inf Model; 2010 Aug; 50(8):1410-7. PubMed ID: 20726599
[TBL] [Abstract][Full Text] [Related]
12. Identification of influenza A pandemic (H1N1) 2009 variants during the first 2009 influenza outbreak in Mexico City.
Zepeda HM; Perea-Araujo L; Zarate-Segura PB; Vázquez-Pérez JA; Miliar-García A; Garibay-Orijel C; Domínguez-López A; Badillo-Corona JA; López-Orduña E; García-González OP; Villaseñor-Ruíz I; Ahued-Ortega A; Aguilar-Faisal L; Bravo J; Lara-Padilla E; García-Cavazos RJ
J Clin Virol; 2010 May; 48(1):36-9. PubMed ID: 20226730
[TBL] [Abstract][Full Text] [Related]
13. Homology modeling, docking, and molecular dynamics reveal HR1039 as a potent inhibitor of 2009 A(H1N1) influenza neuraminidase.
Wang YT; Chan CH; Su ZY; Chen CL
Biophys Chem; 2010 Mar; 147(1-2):74-80. PubMed ID: 20045243
[TBL] [Abstract][Full Text] [Related]
14. Identification of seasonal vaccine hemagglutinin subtype 1 (H1) epitopes in Mexican isolates of the new influenza A (H1N1) 2009 virus.
Rodríguez-Alvarez M; Velasco-Velasco AM; Alvarez-Anell NJ; Jiménez-Corona ME; de León-Rosales SP
Arch Med Res; 2009 Nov; 40(8):687-92. PubMed ID: 20304258
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the nucleotide bias between the novel H1N1 and H5N1 subtypes of influenza A viruses using bioinformatics techniques.
Ahn I; Son HS
J Microbiol Biotechnol; 2010 Jan; 20(1):63-70. PubMed ID: 20134234
[TBL] [Abstract][Full Text] [Related]
16. Insights from investigating the interactions of adamantane-based drugs with the M2 proton channel from the H1N1 swine virus.
Wang JF; Wei DQ; Chou KC
Biochem Biophys Res Commun; 2009 Oct; 388(2):413-7. PubMed ID: 19665993
[TBL] [Abstract][Full Text] [Related]
17. Update: swine influenza A (H1N1) infections--California and Texas, April 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 May; 58(16):435-7. PubMed ID: 19407739
[TBL] [Abstract][Full Text] [Related]
18. Human swine influenza A [H1N1]: practical advice for clinicians early in the pandemic.
Fitzgerald DA
Paediatr Respir Rev; 2009 Sep; 10(3):154-8. PubMed ID: 19651387
[TBL] [Abstract][Full Text] [Related]
19. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
Hou T; Zhu L; Chen L; Xu X
J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
[TBL] [Abstract][Full Text] [Related]
20. Vaccines against influenza A (H1N1) pandemic.
Valdespino-Gomez JL; Garcia-Garcia L; de León-Rosales SP
Arch Med Res; 2009 Nov; 40(8):693-704. PubMed ID: 20304259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
